11 results
8-K
EX-4.1
ACUR
Acura Pharmaceuticals, Inc
28 Jul 17
Entry into a Material Definitive Agreement
12:00am
S-3
EX-4.5
ACUR
Acura Pharmaceuticals, Inc
Shelf registration
9 Mar 16
12:00am
S-3
EX-4.1
ACUR
Acura Pharmaceuticals, Inc
Shelf registration
9 Mar 16
12:00am
S-3
EX-4.1
ACUR
Acura Pharmaceuticals, Inc
Shelf registration
6 Mar 13
12:00am
S-3
EX-4.5
ACUR
Acura Pharmaceuticals, Inc
Shelf registration
6 Mar 13
12:00am
8-K
EX-4.1
lu4neahgx1
21 Aug 07
Acura Pharmaceuticals, Inc. Secures Financing to Fund Pivotal Phase Iii Clinical Trial for Lead Aversion® Technology Product Candidate
12:00am
8-K
EX-4.1
xbisf1f6ry8
10 Feb 04
Other events
12:00am
8-K
EX-4.1
jle0nc
27 Dec 02
Other events
12:00am
8-K
EX-4.2
3btvwl1 ie8lumq
24 Mar 98
Current report
12:00am
8-K
EX-4.1
nta22dfpn rvx
24 Mar 98
Current report
12:00am
10-Q/A
EX-4.1
zrhpa3kj53aequ
27 Aug 96
Quarterly report (amended)
12:00am
- Prev
- 1
- Next